Cyclooxygenase-2 is overexpressed in bladder cancer cells, making it an attractive molecular target for the detection and treatment of cancer. Cyclooxygenase-2 is overexpressed in bladder cancer cells ...
Concurrent chemoradiotherapy (CRT) for bladder cancer: Practice patterns and outcomes in the general population. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract ...
BERLIN -- A Chinese trial that screened advanced urothelial cancer patients for HER2-expression demonstrated a large survival benefit with a novel chemotherapy-free combination in the first-line ...
Bladder cancer was the tenth most prevalent cancer globally in 2020, with 573,000 new cases and 213,000 deaths [1, 2]. Most bladder cancer cases are pathologically classified as urothelial carcinomas, ...
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have ...
Bladder cancer is a rare form of cancer, with a relatively high recovery rate. Recurrence is still an issue; however, with around half of patients affected. Prognostic tests can help identify patients ...
Long-term survivors in both oral PV-10 arms showed an absence of gross bladder tumor at necropsy, a finding not observed in any untreated, vehicle-control, or anti-PD-1 monotherapy animal. Across the ...
Efficacy and safety of neoadjuvant therapy with disitamab vedotin plus toripalimab in treating muscle invasive urothelial bladder cancer followed by selective bladder-preserving or radical cystectomy.
Cyclooxygenase-2 is overexpressed in bladder cancer cells, making it an attractive molecular target for the detection and treatment of cancer. The effects of TKIs on bladder cancer in vivo were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results